Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

OrbusNeich adds sales experience: Genous Bio-engineered R-Stent maker appoints Massimo Chiesa and Per Arne Winberg to its expanding sales and marketing team July 30. Chiesa, who has worked for EuroCor International, Volcano Therapeutics, Jomed and SCIMed (now part of Boston Scientific), is now OrbusNeich's director for Western Europe, the Middle East and Latin America. Winberg brings sales experience from Abbott Vascular, Jomed and Johnson & Johnson/Cordis and becomes director for Northern and Eastern Europe. Antibody-coated Genous was CE-marked in 2005. OrbusNeich touts the device as a safer alternative to drug-eluting stents and is seeking entry into the U.S. market (1"The Gray Sheet" May 28, 2007, p. 5)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025117

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel